Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kendra Garchow"'
Publikováno v:
American Journal of Therapeutics. 22:e97-e106
Treatment for ischemic stroke involves a thrombolytic agent to re-establish blood flow in the brain. However, delayed reperfusion may cause injury to brain capillaries. Previous studies indicate that the antioxidant gamma-L-glutamyl-L-cysteine (γ-Gl
Autor:
Kendra Garchow, Bruce L. Riser, Ernest J. Sukowski, Feridoon Najmabadi, Jeffrey L. Barnes, Darryl R. Peterson
Publikováno v:
The American Journal of Pathology. 184:2908-2921
Fibrosis is at the core of the high morbidity and mortality rates associated with the complications of diabetes and obesity, including diabetic nephropathy (DN), without any US Food and Drug Administration–approved drugs with this specific target.
Autor:
Tatiana Tsoutsman, Bruce L. Riser, Kendra Garchow, Christopher Semsarian, Xiaoyu Wang, Stephen M. Twigg
Publikováno v:
Journal of Molecular and Cellular Cardiology. 62:164-178
Hypertrophic cardiomyopathy (HCM) is the most common inherited primary myocardial disorder. HCM is characterized by interstitial fibrosis and excessive accumulation of extracellular matrix (ECM) proteins. Fibrosis in HCM has been associated with impa
Autor:
Narasimharao Bhagavathula, Patricia Perone, Gary J. Fisher, James Varani, Yiru Xu, Durga Attili, Kendra Garchow, Feridoon Najmabadi, Bruce L. Riser
We recently show that CCN3 is a counter-regulatory molecule for the pro-fibrotic protein CCN2, and a potentially novel fibrosis therapy. The goal of this study was to assess the role of CCN3 in fibroproliferative/fibrotic responses in human dermal fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24d700dcff363027ea46eb4d480933c9
https://europepmc.org/articles/PMC3368017/
https://europepmc.org/articles/PMC3368017/
Autor:
Bruce L. Riser, C. Semsarian, Xiaoyu Wang, Kendra Garchow, Stephen M. Twigg, Tatiana Tsoutsman
Publikováno v:
Heart, Lung and Circulation. 22:S54